YCS21· Other

Humane Genomics

A platform to make artificial viruses as cancer therapeutics.

ActiveChecked 16h ago

Batch: S21
Status, per YC: Active
Team size: 5
HQ: New York City, NY

In S21391 companies, 34% AI

humanegenomics.com YC profile

Founders

Not read from YC yet; the weekly run fills these in.

Same space

Competitors

Closest in what they build, same category.

Kopra BioS24Genetically engineered viruses that teach your immune system to kill…Shared: synthetic biologyActive

Adjacent

Overlapping tags, a different niche.

Also from S21

Batchmates in Summer 2021.

About Humane Genomics

Humane Genomics has developed a platform to engineer cancer killing viruses. We have taken a first principles approach to design and make oncolytic viral therapies. Using a highly lytic RNA virus engineered with "2 factor authentication" (using selective infection and selective replication) they have an on-target to off-target kill ratio > 1000. We are working on our first indication, pediatric liver cancer (hepatoblastoma), with our partners at Texas Children's Hospital, who are world leading experts. We have in vivo (mouse) data showing safety and currently developing efficacy data and are showing 50% reduction in tumor volume.

New York City, NY, USA; New York, NY, USA

Humane Genomics: questions

Which YC batch was Humane Genomics in?

Humane Genomics was in Y Combinator's Summer 2021 batch (S21).

Is Humane Genomics still active?

Y Combinator lists Humane Genomics as active.

Where is Humane Genomics based?

Humane Genomics lists New York City, NY, USA; New York, NY, USA as its location on YC's directory.

Not affiliated with Y Combinator. From YC's public directory. Logos via logo.dev; trademarks belong to their owners.